Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4. (Q45144833)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4. |
scientific article published in November 2004 |
Statements
1 reference
Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4. (English)
1 reference
Sharif Uddin Ahmed
1 reference
Masato Okamoto
1 reference
Tetsuya Oshikawa
1 reference
Tomoyuki Tano
1 reference
Akiko Sasai
1 reference
Shin Kan
1 reference
Tokafumi Hiroshima
1 reference
Hideki Ohue
1 reference
Yoichiro Moriya
1 reference
Yoshiki Ryoma
1 reference
Motoo Saito
1 reference
Mitsunobu Sato
1 reference
1 November 2004
1 reference
1 reference
Identifiers
1 reference